EXHIBIT 31.1




CERTIFICATION OF PRINCIPAL EXECUTIVE
OFFICERAND PRINCIPAL
FINANCIAL AND ACCOUNTING OFFICER


PURSUANT TO RULES 13a-14 AND
15d-14


OF THE SECURITIES EXCHANGE ACT OF
1934




I, Jinyuan Li, Chief Executive
Officer, Chairman and
Acting Chief Financial OfficerofTiens Biotech Group (USA),
Inc.(the “Registrant”), certify that:




1. I have reviewed this quarterly report
on Form 10-Q for theninemonths endedSeptember30, 2010,of the Registrant.




2. Based on my knowledge, this report
does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to
the period covered by this
report;




3. Based on my knowledge, the financial
statements, and other financial information included in thisreport, fairly present in all material
respects the financial condition, results of operations and cash flows of the
Registrant as of, and for,
the periods, presented in this report;




4.I amresponsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
Registrant and
have:




a. Designed such disclosure controls and
procedures, or caused such disclosure controls and procedures to be designed
underoursupervision, to ensure that materialinformation relating to the Registrant, including its consolidated
subsidiaries, is made known tousby others within those entities,
particularly during the period in which this report is being
prepared;




b. Designed such internal control over financial
reporting, or caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financialstatements for external purposes in
accordance with generally accepted accounting principles;





c. Evaluated the effectiveness of the
Registrant’s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of
thedisclosure controls and
procedures, as of the end of the period covered by this report based on such
evaluation;and




d. Disclosed inthis report any change in the
Registrant’s internal control over financial
reporting that occurred during theRegistrant’s most recent fiscal quarterthat has materially affected, or is
reasonably likely to
materially affect, theRegistrant’s internal control over financial
reporting; and




5.I have disclosed, based onmymost recent evaluation of internal
control over
financial reporting, to the
Registrant’s auditorsand the audit committee of the
Registrant’s board of directors (or personsperformingthe equivalent functions):




a. All significant deficiencies and
material weaknesses in the design or operation of internalcontrol over financial reporting which
are reasonablylikely to
adversely affect the Registrant’s ability to record, process, summarize
and report financial information; and




b. Any fraud, whether or not material,
that involves management or other employees whohave a significant role in the
Registrant’s internal control over financial
reporting.




Date:November15,2010/s/ Jinyuan
      LiJinyuan
  LiChief Executive Officer, President
      and Acting Chief
              Financial
      Officer(Principal Executive Officer, Principal Financial
      and
              Accounting
      Officer)